Furthermore, new data from Dr Narod's consortium suggest that tamoxifen does indeed prevent the development of breast cancers in BRCA1 carriers whose tumors are primarily negative (manuscript submitted; J. McClenann, personal communication). The gene discussed is BRCA1; the disease is breast carcinoma.